isofuranodiene has been researched along with paxilline in 1 studies
| Studies (isofuranodiene) | Trials (isofuranodiene) | Recent Studies (post-2010) (isofuranodiene) | Studies (paxilline) | Trials (paxilline) | Recent Studies (post-2010) (paxilline) |
|---|---|---|---|---|---|
| 42 | 0 | 32 | 2,097 | 3 | 790 |
| Protein | Taxonomy | isofuranodiene (IC50) | paxilline (IC50) |
|---|---|---|---|
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 33.55 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 5 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | Homo sapiens (human) | 5 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | Homo sapiens (human) | 5 | |
| BZLF2 | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | 2.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XP; Dang, YY; Lu, JJ; Wang, YT; Xu, WS | 1 |
1 other study(ies) available for isofuranodiene and paxilline
| Article | Year |
|---|---|
Furanodiene presents synergistic anti-proliferative activity with paclitaxel via altering cell cycle and integrin signaling in 95-D lung cancer cells.
Topics: Cell Cycle; Cell Line, Tumor; Curcuma; Cyclin B1; Cyclin D1; Cyclin-Dependent Kinase 6; Drug Synergism; Drugs, Chinese Herbal; Endoplasmic Reticulum Stress; Focal Adhesion Kinase 1; Furans; Heterocyclic Compounds, 2-Ring; Humans; Integrin beta4; Lung Neoplasms; Paclitaxel; Paxillin; Proto-Oncogene Proteins c-myc; Signal Transduction | 2014 |